Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-07-13

FDA Approved: BACLOFEN — Original Application (Medcore LLC)

View source ↗

Summary

FDA approves Medcore LLC's original ANDA for generic baclofen (oral) for the treatment of spasticity associated with multiple sclerosis and spinal cord injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

ORIG AP for BACLOFEN (BACLOFEN)